Chemie und Prozesstechnik
Filtern
Dokumenttyp
Schlagworte
- Magnetic resonance imaging (12)
- Copper (7)
- ELISA (7)
- Mass spectrometry (7)
- Reference material (6)
- Traceability (6)
- Contrast agent (5)
- Fluorescence (5)
- ICP-MS (5)
- Imaging (5)
- MRI (5)
- Metrology (5)
- Peptide (5)
- Peptides (5)
- ATCUN (4)
- Chromatography (4)
- HPLC (4)
- Immunoassay (4)
- LA-ICP-MS (4)
- Nickel (4)
- Peptide library (4)
- Protein G (4)
- Quality control (4)
- Reproducibility (4)
- Screening (4)
- ABID (3)
- Affinity chromatography (3)
- Amino acid analysis (3)
- Antibody (3)
- COVID-19 (3)
- Diagnostics (3)
- Gadofosveset (3)
- Gadolinium (3)
- IgG (3)
- Immunosensor (3)
- Iron disorders (3)
- Lab-on-a-chip (3)
- MALDI (3)
- MALDI-TOF-MS (3)
- Metalloprotein (3)
- Metalloproteins (3)
- Molecular imaging (3)
- Monoclonal antibody (3)
- Nanoparticle (3)
- Peptide mass fingerprinting (3)
- Polymers (3)
- Protein A (3)
- Quality Control (3)
- RBD (3)
- Validation (3)
- 150th anniversary (2)
- AAA (2)
- AAAA (2)
- ABC (2)
- Affinity (2)
- Affinity Chromatography (2)
- Affinitätschromatographie (2)
- Amplification (2)
- Analysis (2)
- Analytical sciences (2)
- Antibodies (2)
- Antibody identification (2)
- Aromatic amino acid analysis (2)
- Atherosclerosis (2)
- BAM (2)
- Bioanalysis (2)
- Bioconjugation (2)
- Biomarker (2)
- Biosensor (2)
- Biotechnology (2)
- Bundesanstalt für Materialforschung und -prüfung (2)
- Calibration (2)
- Cancer (2)
- Clones (2)
- Collection (2)
- Corona (2)
- Database (2)
- Diagnosis (2)
- Documentation (2)
- Dynamische Lichtstreuung (2)
- ESI-MS (2)
- Environment (2)
- Extracellular matrix (2)
- FPLC (2)
- Fingerprint (2)
- Fusion protein (2)
- Glue (2)
- Hybridoma (2)
- Hydrolysis (2)
- Identity (2)
- Immunoaffinity extraction (2)
- Immunocapture (2)
- Immunoglobulins (2)
- Iron oxide (2)
- Jahrestag (2)
- LC-MS (2)
- LC-MS/MS (2)
- Life sciences (2)
- Limit of detection (2)
- MALDI-TOF MS (2)
- MST (2)
- Material sciences (2)
- Method (2)
- Mobile phase (2)
- Monoclonal Antibodies (2)
- Monoclonal antibodies (2)
- Nitrotyrosine (2)
- OBOC library (2)
- Open Science (2)
- Peptide analysis (2)
- Peptide pools (2)
- Permethrin (2)
- Phenylalanine (2)
- Plasma (2)
- Pollutant (2)
- Prostate cancer (2)
- Protein hydrolysis (2)
- Protein quantification (2)
- Quality assurance (2)
- Quantitative protein analysis (2)
- RP-HPLC (2)
- Reference materials (2)
- Regeneration (2)
- Reproducibility crisis (2)
- Ring resonator (2)
- SARS-CoV-2 (2)
- SBA-15 (2)
- SDS-PAGE (2)
- SUMO (2)
- Sensor (2)
- Sequence coverage (2)
- Sequencing (2)
- Serum (2)
- Software (2)
- Special issue (2)
- Spike-Protein (2)
- Synthetic peptides (2)
- Trypsin (2)
- Tyrosine (2)
- Virus (2)
- 150th anniversary of BAM (1)
- 2,5-dihydroxyacetophenone (1)
- 280 nm (1)
- 6xHis (1)
- ACE2 (1)
- ACE2-Rezeptor (1)
- ADAMTS4 (1)
- Acid (1)
- Acidic cleavage (1)
- Acute myocardial infarction (1)
- Additive Manufacturing (1)
- Adhesion (1)
- Adhesives (1)
- Adsorption (1)
- Affinity Extraction (1)
- Affinity Separation (1)
- Affinity enrichment (1)
- Affinity extraction (1)
- Affinitätskonstante (1)
- Agarose (1)
- Air filter samples (1)
- Air particulate matter (1)
- Air traffic (1)
- Airport (1)
- Alanine scan (1)
- Albumin (1)
- Alkylierung (1)
- Allergy (1)
- Aluminiumoxid (1)
- Aluminum oxide (1)
- Ameisensäure (1)
- Aneurysm (1)
- Angiography (1)
- Angiotensin II (1)
- Anthropocene (1)
- Antibiotics (1)
- Antibody Purification (1)
- Antibody coating (1)
- Antibody light chain (1)
- Antibody quantification (1)
- Antibody subclass (1)
- Antibody-gated indicator delivery (1)
- Antikörper (1)
- Aorta (1)
- Aromatische Aminosäureanalytik (1)
- Array (1)
- Atherosclerotic plaques (1)
- Atmospheric aerosol (1)
- Automated Purification (1)
- Aviation (1)
- BCA (1)
- BCA test (1)
- BSA (1)
- Back-side integration (1)
- Bacterial lysates (1)
- Basic solvent (1)
- Benchmarking study (1)
- Benzene-1,3,5-tricarboxylic acid (1)
- Binder (1)
- Binding molecule (1)
- Biochemistry (1)
- Biochip (1)
- Bioconjugates (1)
- Bioinformatics (1)
- Biosensing (1)
- Biosensors (1)
- Bioseparation (1)
- Block copolymer (1)
- Blood (1)
- Bombs (1)
- Border surveillance (1)
- Borosilicate Glass (1)
- Borosilicatglas (1)
- Bovine serum albumin (BSA) (1)
- Bradford (1)
- Bradford-Assay (1)
- CCMV (1)
- CMOS (1)
- Cardiac troponin (1)
- Cardiovascular (1)
- Cardiovascular diseases (1)
- Carrier (1)
- Carrier-Material (1)
- Ceruloplasmin (1)
- Chelate (1)
- Chemical protein modification (1)
- Chemiluminescence (1)
- Chicken antibodies (1)
- Chip (1)
- Chip-Screening (1)
- Chronic kidney disease (1)
- Citation (1)
- Citizen Science (1)
- Cleavage (1)
- Clinical samples (1)
- Collagen (1)
- Collision induced dissociation (CID) (1)
- Column holder (1)
- Combinatorial chemistry (1)
- Combinatorial library (1)
- Combinatorial screening (1)
- Combustion (1)
- Competitive Immunoassay (1)
- Compound-independent calibration (1)
- Concentration step (1)
- Confiscation (1)
- Construction (1)
- Continuous Sensor (1)
- Corona virus (1)
- Coronavirus (1)
- Covalent conjugation (1)
- Crossreactivity (1)
- Customs (1)
- Cyclisierung (1)
- Cytoplasm (1)
- DHAP (1)
- DLS (1)
- Damage-associated molecular patterns (DAMPs) (1)
- Data analysis (1)
- De novo peptide sequencing (1)
- Deep learning-based tools (1)
- Delivery system (1)
- Derivatization (1)
- Detection (1)
- Diagnostic (1)
- Diagnostic Antibodies (1)
- Diesel exhaust (1)
- Digestion (1)
- Dityrosine (1)
- Docking (1)
- Double strands (1)
- Down Stream Processing (1)
- Downstream Processing (1)
- Downstream processing (1)
- Drug search (1)
- Drug trafficking (1)
- Drug transporters (1)
- Drugs (1)
- Duftstoffe (1)
- Durchflusszytometrie (1)
- E. coli (1)
- EDTAD (1)
- EP-3533 (1)
- ESMA (1)
- Editorial (1)
- Elastin-specific contrast agent ESMA (1)
- Elastin-specific molecular agent (1)
- Element Specific Bioimaging Using Laser Ablation (1)
- Emergency (1)
- Environmental pollutants (1)
- Epoxy (1)
- Error correction (1)
- Escherichia coli (1)
- Ethylenediaminetetraacetic acid (1)
- Etofenprox (1)
- Exhaust (1)
- Experiment (1)
- Explosives (1)
- Expression (1)
- Fab Fragment (1)
- False Positives (1)
- Ferumoxytol (1)
- Festphasenextraktion (1)
- Flow injection immunoassay (1)
- Fluorescence label (1)
- Fluoreszenz (1)
- Formulation additives (1)
- Fragment (1)
- Functionalization (1)
- Gadolinium-based contrast agent (1)
- Gadovist (1)
- Gated hybrid material (1)
- Gd-DOTA (1)
- Ggadolinium (1)
- Github (1)
- Glass (1)
- Glass Support (1)
- Gold particles (1)
- Gold-Nanopartikel (1)
- Größenausschlusschromatographie (1)
- HTS (1)
- Halomonas elongata (1)
- Hapten Immunoassay (1)
- Hard protein corona (1)
- Hay fever (1)
- Heart attack (1)
- Heavy chains (1)
- Hepatocellular carcinoma (1)
- HexaHis-Tag (1)
- High pH (1)
- High-Speed (1)
- High-Speed Separations (1)
- Highspeed (1)
- His6 (1)
- His8 (1)
- Histidine (1)
- Hochdurchsatzscreening (1)
- Human Plasma (1)
- Human serum albumin (1)
- Hydrochloric acid (1)
- IC50 (1)
- IMAC purification (1)
- IgG determination (1)
- IgY (1)
- Iinductively coupled plasma mass spectrometry (1)
- Illicit drug (1)
- Illumina (1)
- Immobilisierung (1)
- Immunglobuline (1)
- Immunoaffinity (1)
- Immunoassays (1)
- Immunometric assay (1)
- Immunometric biosensor (1)
- Immunoprecipitation (1)
- Immunpräzipitation (1)
- Impact (1)
- In-vivo (1)
- Inductively Coupled Mass Spectroscopy (1)
- Inductively coupled plasma mass spectroscopy (1)
- Inductively‑coupled mass spectrometry (1)
- Insecticide (1)
- Internal standard (1)
- Internal standards (1)
- International drug trade (1)
- Ion mobility spectrometry (1)
- Iron deficiency (1)
- Isotope dilution (1)
- Java GUI (1)
- Kjeldahl (1)
- Klon A1.1.1 (1)
- Klon EW75C (1)
- Korrelationsmatrix (1)
- Kreuzreaktion (1)
- LC-MS/MS peptide quantification (1)
- LC-UV absorbance (1)
- LFIA (1)
- Lab-on-a-Chip (1)
- Ladder sequencing (1)
- Laser ablation (1)
- Laser ablation-inductively coupled plasma-mass spectrometry (1)
- Laser ablation-inductively coupled plasma-mass spectroscopy (1)
- Lateral flow assay (1)
- Lateral flow immunoassays (1)
- Lateral flow test (1)
- Latex particles (1)
- Library (1)
- Light chain (1)
- Light chains (1)
- Liquid chromatography (1)
- Locked nucleic acids (1)
- Luminol (1)
- MALDI-TOF mass spectrometry (1)
- MR Angiography (1)
- MR imaging (1)
- Macrophages (1)
- Mass spectroscopy (MS) (1)
- Massenspektrometrie (1)
- Material-binding Peptides (1)
- Medicine (1)
- Mesoporous particles (1)
- Metal complex (1)
- Microfluidic system (1)
- Microfluidics (1)
- Mikroparticles (1)
- Missing fragmentation sites (1)
- Molecular MRI (1)
- Molecular marker (1)
- Molecular-MRI (1)
- Monoclonal Antibody (1)
- Monolith (1)
- Monolithic column (1)
- Mutationen (1)
- NIST (1)
- NIST-mAb 8671 (1)
- NMR (1)
- NaCl-Methode (1)
- Nanobody (1)
- Nanodiamant (1)
- Nanoparticles (1)
- Narcotics (1)
- Neutralisierende Antikörper (1)
- Nickel chelate (1)
- Nitration (1)
- Nitroaromaten (1)
- Nitromoschus (1)
- Nucleocapsid (1)
- Nucleocapsid-Protein (1)
- OBOC (1)
- Oligonucleotide fragmentation (1)
- On-chip screening (1)
- One-bead-one-compound library (1)
- Online biosensor (1)
- Online software (1)
- Open science (1)
- Optical detection (1)
- Oriented immobilization (1)
- Osmotic minipumps (1)
- PEG (1)
- PIC technology (1)
- Partikel (1)
- Pattern recognition receptor (1)
- Peak overlap (1)
- Peer review (1)
- Peptid-Aptamer (1)
- Peptid-Synthese (1)
- Peptidbibliothek (1)
- Peptidbibliotheken (1)
- Peptide Library (1)
- Peptide aptamers (1)
- Peptide coverage (1)
- Peptide library screening (1)
- Peptide losses (1)
- Peptide probe (1)
- Peptidsequenzierung (1)
- Periplasma (1)
- Peroxidase (1)
- Pesticide (1)
- Pflanzenvirus (1)
- Pharmaceutical (1)
- Pharmaceuticals (1)
- Phenothrin (1)
- Phenylketonuria (1)
- Photonic Integrated Circuits (1)
- Photonic Sensor (1)
- Photonic biosensor (1)
- Plastics (1)
- Point-Of-Care-Diagnostics (1)
- Polishing (1)
- Pollen extract (1)
- Polyclonal Antibodies (1)
- Polymer (1)
- Polymer-binding Peptides (1)
- Polypropylene (1)
- Precision Profile (1)
- Preprocessing (1)
- Primer (1)
- Protein (1)
- Protein Purification (1)
- Protein content (1)
- Protein g (1)
- Protein nitration (1)
- Protein oligomerization (1)
- Protein test (1)
- Proximity-enhanced reaction (1)
- Präzisionsprofil (1)
- Purification (1)
- Purity (1)
- Pyrethroid (1)
- Pyrethroids (1)
- QC (1)
- Raid test (1)
- Recombinant Antibody (1)
- Recombinant antibody (1)
- Recombinant protein (1)
- Recovery (1)
- References (1)
- Reinigung (1)
- Rekombinante Antikörper (1)
- Replication (1)
- Replication crisis (1)
- Resonance wavelength shift (1)
- Risk assessment (1)
- Robustness (1)
- Round robin exercise (1)
- Round robin test (1)
- SAFIA (1)
- SALSA (1)
- SARS-CoV-2 antibody (1)
- SBA-16 (1)
- SI traceability (1)
- SPR (1)
- Sanger sequencing (1)
- Sapphire (1)
- Saure Hydrolyse (1)
- Scientific publication (1)
- Separation (1)
- Sequencing algorithm (1)
- Sequenzierung (1)
- Silanization (1)
- Silicon Photonics (1)
- Sintered Material (1)
- Smartphone readout device (1)
- Sodium chloride method (1)
- Soft protein corona (1)
- Solid support (1)
- Solid-binding Peptides (1)
- Specific probe (1)
- Spike protein (1)
- Stationäre Phase (1)
- Sulfur (1)
- Sulfuric acid (1)
- Supernatant (1)
- Surface Activation (1)
- Surface plasmon resonance (1)
- Surrogate citations (1)
- TNT (1)
- Target (1)
- Terephthalic acid (1)
- Terrorism (1)
- Test strip (1)
- Tetracyclin (1)
- Therapeutic Antibodies (1)
- Tomography (1)
- Topical collection: Analytical Methods and Applications in the Materials and Life Sciences (1)
- Trennung (1)
- Trinitrotoluol (1)
- Trust (1)
- Tryptic digest (1)
- Tryptophan (1)
- Tumor (1)
- Type-I pyrethroids (1)
- UHPLC-MS/MS (1)
- Ultraschall (1)
- Ultrasensitive (1)
- Vhh (1)
- Visualization (1)
- ZIF (1)
- Zenodo (1)
Organisationseinheit der BAM
- 1.5 Proteinanalytik (76) (entfernen)
Eingeladener Vortrag
- nein (2)
Antikörper sind in der medizinischen Welt nicht mehr wegzudenken. Ihr Einsatz-Repertoire als Therapeutika für die Behandlung diverser Krankheiten und Infektionen weitet sich von Jahr zu Jahr mehr aus. Dabei basiert ein Großteil der verwendeten Antikörper zu diesem Zeitpunkt auf monoklonalen Antikörpern auf Basis von Hybridomazellen. Doch hier könnten rekombinante Antikörper aufgrund ihrer Vektor-basierten Expression eine vielversprechende und womöglich sogar revolutionierende Alternative bieten. So ergeben sich neue Optimierungsoptionen für Merkmale wie Affinität, Stabilität und Kompatibilität über Anpassungen auf genetischer oder posttranslationaler Ebene. Allerdings ergibt sich kein Anwendungszweck ohne die vorhergehende detaillierte Charakterisierung der Antikörper. Denn nur mit spezifischem Wissen über die diversen Eigenschaften und Wechselwirkungen kann eine effektive und präzise Verwendung in der Diagnostik und Therapeutik gewährleistet werden und auf diese Weise Leben retten.
Aus diesem Grund beschäftigt sich diese Masterarbeit mit der Vertiefung der rekombinanten Antikörper-Thematik. Dazu soll ein Anti-Tetanus-Antikörper erstmals rekombinant in verschiedenen Zelllinien hergestellt und anschließend über umfangreiche analytische Verfahren mit einem Fokus auf die Einflussanalyse der unterschiedlichen posttranslationalen Glykosylierungen charakterisiert werden. Zu diesem Zweck wurden als Grundlage einerseits zwei P1316-Dual-Expressions-Vektoren mit variierenden Insert-Positionen der schweren und leichten Kette durch Gibson-Assembly sowie individuellen pRK5-Plasmide für eine separiert Expression der Antikkörperketten mithilfe Restriktionsfragment-Ligation generiert. In einer Gegenüberstellung der der Expressionsausbeuten stellte sich die Überlegenheit der P1316-Plasmid-Konfiguration heraus, in der das Leichtketten-Insert an der ersten Expressionsstelle positioniert ist. Deshalb wurde dieser Vektor als Ausgangspunkt für die anschließende hochskalierten Herstellung des Anti-Tetanus-Antikörpers in Expi293F-GnTI- und ExpiCHO-S-Zellen verwendet. Ein ELISA bestätigte die Bindungsaktivität der rekombinanten Antikörper am Tetanus-Toxoid unabhängig vom Expressionssystem. Nach einer folgenden Optimierung der für die Aufreinigung verwendeten Protein-A-Affinitätschromatographie, wurde über weitere Charakterisierungsmethoden wie Größenausschlusschromatographie und dynamische Lichtstreuung eine vergleichbare Aggregation aufgrund der sauren Elution aufgezeigt. In diesem Kontext wurde die Notwendigkeit einer Zweistufen-Präparation mit Affinitäts- und Größenausschlusschromatografie für den Erhalt monodisperser Proben verdeutlicht. Zudem wurden die verschiedenen intakten Massen mitsamt ihrer spezifischen Glykan-abhängigen Streumaßen in Relation zum monoklonalen NISTmAB-Referenzantikörper bestimmt. Dabei konnte den Erwartungen nach sowohl die geringere Masse als auch die uniformere Glykosylierung der in Expi293 GnTI- exprimierten Immunoglobuline in Relation zum ExpiCHO-S-Antikörper nachgewiesen werden. Anschließend wurde das Stabilitätsverhalten mittels thermischer Entfaltung und dynamischer Lichtstreuung über einen ausgeweiteten Zeitraum sowie verschiedenen Temperaturen dokumentiert. Grundlegend wurde eine höhere thermische Stabilität der zweiten konstanten Schwerketten-Domäne des aus ExpiCHO-S-Zellen stammenden Antikörpers nachgewiesen. Außerdem konnte eine problemlose Lagerungsfähigkeit beider unterschiedlich glykosylierter Antikörper bei Raumtemperatur für mindestens 4 Wochen festgestellt werden. Des Weiteren wurde die Langzeitlagerung im Rahmen der Auswirkung von Gefrier-Auftau-Zyklen mit gleichbleibenden Methoden sowie zusätzlicher Größenausschlusschromatographie erprobt. Hierbei stellte sich der Erhalt der strukturellen Integrität nach bis zu 15 Zyklen heraus. Allerdings geht die Monodispersität bereits nach wenigen Zyklen verloren, wobei die geringfügiger glykosylierten Expi293F-GnTI-Anti-Tetanus-Antikörper eine stärkere Beeinträchtigung durch multiple Gefrier-Auftau-Zyklen aufwiesen.
Cardiac troponin I (cTnI) is a crucial biomarker for diagnosing cardiac vascular diseases, including acute myocardial infarction (AMI). This study presents a proof-of-concept chemiluminescence-based immunosensor for rapid and accurate measurement of cTnI, with the potential for online monitoring. The immunosensor incorporates a flow cell design and a sensitive complementary metal-oxide-semiconductor (CMOS) camera for optical readout. A microfluidic setup was established to enable selective and quasi-online determination of cTnI within ten minutes. The sensor was tested with recombinant cTnI in phosphate buffer, demonstrating measurements in the concentration range of 2–25 µg/L, with a limit of detection (LoD) of 0.6 µg/L (23 pmol/L) achieved using the optimized system. The immunosensor exhibited high selectivity, as no cross-reactivity was observed with other recombinant proteins such as cTnT and cTnC at a concentration of 16 µg/L. Measurements with diluted blood plasma and serum yielded an LoD of 60 µg/L (2.4 nmol/L) and 70 µg/L (2.9 nmol/L), respectively. This biosensor offers a promising approach for the rapid and sensitive detection of cTnI, contributing to the diagnosis and management of acute myocardial infarction and other cardiac vascular diseases.
Immobilized metal affinity chromatography (IMAC) is a widely used technique for purifying polyhistidine-tagged recombinant proteins. However, it often has practical limitations that require complex optimizations and additional steps for purification. In this study, we introduce functionalized corundum particles as a novel, efficient, and economical method for purifying recombinant proteins in a column-free format. The corundum surface is modified with amino silane APTES, followed by EDTA dianhydride, and then loaded with nickel ions. We used the Kaiser test to monitor the modification process and ICP-MS to quantify the metal-binding capacity. To evaluate the system, we used His-tagged protein A/G (PAG) mixed with bovine serum albumin (BSA). The corundum particles exhibited a binding capacity of approximately 3 mg of protein per gram of corundum or 2.4 mg per 1 mL of corundum suspension. We also examined cytoplasm obtained from different E. coli strains as an example of a complex matrix. Varying the imidazole concentration in the loading and washing buffers showed that higher concentrations during loading improved purity. Even with sample volumes as large as one liter, we successfully isolated recombinant proteins down to a concentration of 1 µg/mL. We found higher purity levels with corundum when comparing the corundum material to standard Ni–NTA agarose beads. We successfully purified His6-MBP-mSA2, a fusion protein comprising monomeric streptavidin and maltose-binding protein, from E. coli cytoplasm, demonstrating the method's applicability. We also purified SARS-CoV-2-S-RBD-His8 expressed in human Expi293F cells, confirming its suitability for mammalian cell culture supernatants. The material cost of the nickel-loaded corundum material (without regeneration) is estimated to be less than 30 cents per gram of functionalized support or 10 cents per milligram of isolated protein. Another advantage of this system is the exceptional physical and chemical stability of corundum particles. Overall, we have demonstrated that this novel material offers an efficient, robust, and cost-effective purification platform for His-tagged proteins, even in challenging, complex matrices and large sample volumes with low product concentrations. This method has potential applications in both small laboratories and large-scale industrial settings.
Quantitative 1H Nuclear Magnetic Resonance (qNMR) of Aromatic Amino Acids for Protein Quantification
(2023)
Hydrolysis of protein samples into amino acids facilitates the use of NMR spectroscopy for protein and peptide quantification. Different conditions have been tested for quantifying aromatic amino acids and proteins. The pH-dependent signal shifts in the aromatic region of amino acid samples were examined. A pH of 12 was found to minimize signal overlap of the four aromatic amino acids. Several aromatic compounds, such as terephthalic acid, sulfoisophthalic acid, and benzene tricarboxylic acid, were applied as internal standards. The quantification of amino acids from an amino acid standard was performed. Using the first two suggested internal standards, recovery was ~97% for histidine, phenylalanine, and tyrosine at a concentration of approximately 1 mM in solution. Acidic hydrolysis of a certified reference material (CRM) of bovine serum albumin (BSA) and subsequent quantification of Phe and Tyr yielded recoveries of 98% ± 2% and 88% ± 4%, respectively, at a protein concentration of 16 g/L or 250 µM.
Comprehensive evaluation of peptide de novo sequencing tools for monoclonal antibody assembly
(2023)
Monoclonal antibodies are biotechnologically produced proteins with various applications in research, therapeutics and diagnostics. Their ability to recognize and bind to specific molecule structures makes them essential research tools and therapeutic agents. Sequence information of antibodies is helpful for understanding antibody–antigen interactions and ensuring their affinity and specificity. De novo protein sequencing based on mass spectrometry is a valuable method to obtain the amino acid sequence of peptides and proteins without a priori knowledge. In this study, we evaluated six recently developed de novo peptide sequencing algorithms (Novor, pNovo 3, DeepNovo, SMSNet, PointNovo and Casanovo), which were not specifically designed for antibody data. We validated their ability to identify and assemble antibody sequences on three multi-enzymatic data sets. The deep learning-based tools Casanovo and PointNovo showed an increased peptide recall across different enzymes and data sets compared with spectrum-graph-based approaches. We evaluated different error types of de novo peptide sequencing tools and their performance for different numbers of missing cleavage sites, noisy spectra and peptides of various lengths. We achieved a sequence coverage of 97.69–99.53% on the light chains of three different antibody data sets using the de Bruijn assembler ALPS and the predictions from Casanovo. However, low sequence coverage and accuracy on the heavy chains demonstrate that complete de novo protein sequencing remains a challenging issue in proteomics that requires improved de novo error correction, alternative digestion strategies and hybrid approaches such as homology search to achieve high accuracy on long protein sequences.
Constant interactions between tumor cells and the extracellular matrix (ECM) influence the progression of prostate cancer (PCa). One of the key components of the ECM are collagen fibers, since they are responsible for the tissue stiffness, growth, adhesion, proliferation, migration, invasion/metastasis, cell signaling, and immune recruitment of tumor cells. To explore this molecular marker in the content of PCa, we investigated two different tumor volumes (500 mm3 and 1000 mm3) of a xenograft mouse model of PCa with molecular magnetic resonance imaging (MRI) using a collagen-specific probe. For in vivo MRI evaluation, T1-weighted sequences before and after probe administration were analyzed. No significant signal difference between the two tumor volumes could be found. However, we detected a significant difference between the signal intensity of the peripheral tumor area and the central area of the tumor, at both 500 mm3 (p < 0.01, n = 16) and at 1000 mm3 (p < 0.01, n = 16). The results of our histologic analyses confirmed the in vivo studies: There was no significant difference in the amount of collagen between the two tumor volumes (p > 0.05), but within the tumor, higher collagen expression was observed in the peripheral area compared with the central area of the tumor. Laser ablation with inductively coupled plasma mass spectrometry further confirmed these results. The 1000 mm3 tumors contained 2.8 +- 1.0% collagen and the 500 mm3 tumors contained 3.2 +- 1.2% (n = 16). There was a strong correlation between the in vivo MRI data and the ex vivo histological data (y = 0.068x + 1.1; R2 = 0.74) (n = 16). The results of elemental analysis by inductively coupled plasma mass spectrometry supported the MRI data (y = 3.82x + 0.56; R2 = 0.79; n = 7). MRI with the collagen-specific probe in PCa enables differentiation between different tumor areas. This may help to differentiate tumor from healthy tissue, potentially identifying tumor areas with a specific tumor biology.
Quantitative 1H Nuclear Magnetic Resonance (qNMR) of Aromatic Amino Acids for Protein Quantification
(2022)
qNMR is a valuable technique for metrological studies due to the uniformity of its signal response for all chemical species of an isotope of interest, which enables compound-independent calibration. However, protein quantification remained challenging as large molecules produce wide, low-intensity signals that reduce the already low sensitivity. Combining qNMR with the hydrolysis of protein samples into amino acids circumvents many of these issues and facilitates the use of NMR spectroscopy for absolute protein and peptide quantification.In this work, different conditions have been tested for quantifying aromatic amino acids and proteins. First, we examined the pH-based signal shifts in the aromatic region. The preferable pH depends on the selection of the amino acids for quantification and which internal standard substance should be used to avoid peak overlap. Several aromatic compounds, such as terephthalic acid, sulfoisophthalic acid, and benzene tricarboxylic acid, have been applied as internal standards. The quantification of amino acids from an amino acid standard, as well as from a certified reference material (bovine serum albumin), was performed. Using the first two suggested internal standards, recovery was ~ 97 % for histidine, phenylalanine, and tyrosine at a concentration of approximately 1 mM in solution. Acidic hydrolysis of a certified reference material (CRM) of bovine serum albumin (BSA) and subsequent quantification of Phe and Tyr yielded recoveries of 98 ± 2 and 88 ± 4 %, respectively, at a protein concentration of 16 g/L or 250 µM.
Screening against ADAMTS4 reveals a specific peptide, which was turned into an MRI probe. The aneurysm in a mouse modal was visualized via MRI. A differentiation between stable and unstable aneurysm in an early state was performed. Using the probe as tool for an easy and non-invasive rupture assessment is possible.
ABID
(2022)
In order to automate the spectral comparison for larger libraries of antibodies, we developed the online software ABID 2.0. This open-source software determines the number of matching peptides in the fingerprint spectra. We propose that publications and other documents critically relying on monoclonal antibodies with unknown amino acid sequences should include at least one antibody fingerprint. By fingerprinting an antibody in question, its identity can be confirmed by comparison with a library spectrum at any time and context.
ADAMTS4-specific MR-probe to assess aortic aneurysms in vivo using synthetic peptide libraries
(2022)
The incidence of abdominal aortic aneurysms (AAAs) has substantially increased during the last 20 years and their rupture remains the third most common cause of sudden death in the cardiovascular field after myocardial infarction and stroke. The only established clinical parameter to assess AAAs is based on the aneurysm size. Novel biomarkers are needed to improve the assessment of the risk of rupture. ADAMTS4 (A Disintegrin And Metalloproteinase with ThromboSpondin motifs 4) is a strongly upregulated proteoglycan cleaving enzyme in the unstable course of AAAs. In the screening of a one-bead-one-compound library against ADAMTS4, a low-molecular-weight cyclic peptide is discovered with favorable properties for in vivo molecular magnetic resonance imaging applications. After identification and characterization, it’s potential is evaluated in an AAA mouse model. The ADAMTS4-specific probe enables the in vivo imaging-based prediction of aneurysm expansion and rupture.
Current trends in materials and life sciences are flanked by the need to push detection limits to single molecules or single cells, enable the characterization of increasingly complex matrices or sophisticated nanostructures, speed up the time of analysis, reduce instrument complexity and costs, and improve the reliability of data. This requires suitable analytical tools such as spectroscopic, separation and imaging techniques, mass spectrometry, and hyphenated techniques as well as sensors and their adaptation to application-specific challenges in the environmental, food, consumer product, health sector, nanotechnology, and bioanalysis. Increasing concerns about health threatening known or emerging pollutants in drinking water, consumer products, and food and about the safety of nanomaterials led to a new awareness of the importance of analytical sciences. Another important driver in this direction is the increasing demand by legislation, particularly in view of the 17 sustainable development goals by the United Nations addressing clean energy, industry, and innovation, sustainable cities, clean water, and responsible consumption and production. In this respect, also the development of analytical methods that enable the characterization of material flows in production processes and support recycling concepts of precious raw materials becomes more and more relevant. In the future, this will provide the basis for greener production in the chemical industry utilizing recycled or sustainable starting materials.
This makes analytical chemistry an essential player in terms of the circular economy helping to increase the sustainability of production processes. In the life sciences sector, products based on proteins, such as therapeutic and diagnostic antibodies, increase in importance. These increasingly biotechnologically produced functional biomolecules pose a high level of complexity of matrix and structural features that can be met only by highly advanced methods for separation, characterization, and detection. In addition, metrological traceability and target definition are still significant challenges for the future, particularly in the life sciences.
However, innovative reference materials as required for the health and food sector and the characterization of advanced materials can only be developed when suitable analytical protocols are available. The so-called reproducibility crisis in sciences underlines the importance of improved measures of quality control for all kinds of measurements and material characterization. This calls for thorough method validation concepts, suitable reference materials, and regular interlaboratory comparisons of measurements as well as better training of scientists in analytical sciences.
The important contribution of analytical sciences to these developments is highlighted by a broad collection of research papers, trend articles, and critical reviews from these different application fields. Special emphasis is dedicated to often-overlooked quality assurance and reference materials.
Current trends in materials and life sciences are flanked by the need to push detection limits to single molecules or single cells, enable the characterization of increasingly complex matrices or sophisticated nanostructures, speed up the time of analysis, reduce instrument complexity and costs, and improve the reliability of data. This requires suitable analytical tools such as spectroscopic, separation and imaging techniques, mass spectrometry, and hyphenated techniques as well as sensors and their adaptation to application-specific challenges in the environmental, food, consumer product, health sector, nanotechnology, and bioanalysis. Increasing concerns about health threatening known or emerging pollutants in drinking water, consumer products, and food and about the safety of nanomaterials led to a new awareness of the importance of analytical sciences. Another important driver in this direction is the increasing demand by legislation, particularly in view of the 17 sustainable development goals by the United Nations addressing clean energy, industry, and innovation, sustainable cities, clean water, and responsible consumption and production. In this respect, also the development of analytical methods that enable the characterization of material flows in production processes and support recycling concepts of precious raw materials becomes more and more relevant. In the future, this will provide the basis for greener production in the chemical industry utilizing recycled or sustainable starting materials.
This makes analytical chemistry an essential player in terms of the circular economy helping to increase the sustainability of production processes. In the life sciences sector, products based on proteins, such as therapeutic and diagnostic antibodies, increase in importance. These increasingly biotechnologically produced functional biomolecules pose a high level of complexity of matrix and structural features that can be met only by highly advanced methods for separation, characterization, and detection. In addition, metrological traceability and target definition are still significant challenges for the future, particularly in the life sciences.
However, innovative reference materials as required for the health and food sector and the characterization of advanced materials can only be developed when suitable analytical protocols are available. The so-called reproducibility crisis in sciences underlines the importance of improved measures of quality control for all kinds of measurements and material characterization. This calls for thorough method validation concepts, suitable reference materials, and regular interlaboratory comparisons of measurements as well as better training of scientists in analytical sciences.
The important contribution of analytical sciences to these developments is highlighted by a broad collection of research papers, trend articles, and critical reviews from these different application fields. Special emphasis is dedicated to often-overlooked quality assurance and reference materials.
Prostate cancer (PCa) is one of the most common cancers in men. For detection and diagnosis of PCa, non-invasive methods, including magnetic resonance imaging (MRI), can reduce the risk potential of surgical intervention. To explore the molecular characteristics of the tumor, we investigated the applicability of ferumoxytol in PCa in a xenograft mouse model in two different tumor volumes, 500 mm3 and 1000 mm3. Macrophages play a key role in tumor progression, and they are able to internalize iron-oxide particles, such as ferumoxytol. When evaluating T2*-weighted sequences on MRI, a significant decrease of signal intensity between pre- and post-contrast images for each tumor volume (n = 14; p < 0.001) was measured. We, furthermore, observed a higher signal loss for a tumor volume of 500 mm3 than for 1000 mm3. These findings were confirmed by histological examinations and laser ablation inductively coupled plasma-mass spectrometry. The 500 mm3 tumors had 1.5% iron content (n = 14; sigma = 1.1), while the 1000 mm3 tumors contained only 0.4% iron (n = 14; sigma = 0.2). In vivo MRI data demonstrated a correlation with the ex vivo data (R2 = 0.75). The results of elemental analysis by inductively coupled plasma-mass spectrometry correlated strongly with the MRI data (R2 = 0.83) (n = 4). Due to its long retention time in the blood, biodegradability, and low toxicity to patients, ferumoxytol has great potential as a contrast agent for visualization PCa.
Under the auspices of the Protein Analysis Working Group (PAWG) of the Comité Consultatif pour la Quantité de Matière (CCQM) a pilot study, CCQM-P216, was coordinated by the Chinese National Institute of Metrology (NIM), National Research Council of Canada (NRC) and the Bureau International des Poids et Mesures (BIPM). Eleven Metrology Institutes or Designated Institutes and the BIPM participated in the first phase of the pilot study (Part 1). The purpose of this pilot study was to develop measurement capabilities for larger proteins using a recombinant humanized IgG monoclonal antibody against Spike glycoprotein of SARS-CoV-2 (Anti-S IgG mAb) in solution. The first phase of the study was designed to employ established methods that had been previously studies by the CCQM Protein Analysis Working Group, involving the digestion of protein down to the peptide or amino acid level. The global coronavirus pandemic has also led to increased focus on antibody quantitation methods. IgG are among the immunoglobulins produced by the immune system to provide protection against SARS-CoV-2. Anti-SARS-CoV-2 IgG can therefore be detected in samples from affected patients. Antibody tests can show whether a person has been exposed to the SARS-CoV-2, and whether or not they potentially show lasting immunity to the disease. With the constant spread of the virus and the high pressure of re-opening economies, antibody testing plays a critical role in the fight against COVID-19 by helping healthcare professionals to identify individuals who have developed an immune response, either via vaccination or exposure to the virus. Many countries have launched large-scale antibody testing for COVID-19. The development of measurement standards for the antibody detection of SARS-CoV-2 is critically important to deal with the challenges of the COVID-19 pandemic. In this study, the SARS-CoV-2 monoclonal antibody is being used as a model system to build capacity in methods that can be used in antibody quantification. Amino acid reference values with corresponding expanded uncertainty of 36.10 ± 1.55 mg/kg, 38.75 ± 1.45 mg/kg, 18.46 ± 0.78 mg/kg, 16.20 ± 0.67 mg/kg and 30.61 ± 1.30 mg/kg have been established for leucine, valine, phenylalanine, isoleucine and proline, respectively. Agreement between nearly all laboratories was achieved for the amino acid analysis within 2 to 2.5 %, with one participant achieving markedly higher results due to a technical issue found in their procedure; this result was thus excluded from the reference value calculations. The relatively good agreement within a laboratory between different amino acids was not dissimilar to previous results for peptides or small proteins, indicating that factors such as hydrolysis conditions and calibration procedures could be the largest sources of variability. Peptide reference values with corresponding expanded uncertainty of 4.99 ± 0.28 mg/kg and 6.83 ± 0.65 mg/kg have been established for ALPAPIEK and GPSVFPLAPSSK, respectively. Not surprisingly due to prior knowledge from previous studies on peptide quantitation, agreement between laboratories for the peptide-based analysis was slightly poorer at 3 to 5 %, with one laboratory's result excluded for the peptide GPSVFPLAPSSK. Again, this level of agreement was not significantly poorer than that achieved in previous studies with smaller or less complex proteins. To reach the main text of this paper, click on Final Report.
MALDI-TOF-MS-Based Identification of Monoclonal Murine Anti-SARS-CoV-2 Antibodies within One Hour
(2022)
During the SARS-CoV-2 pandemic, many virus-binding monoclonal antibodies have been developed for clinical and diagnostic purposes. This underlines the importance of antibodies as universal bioanalytical reagents. However, little attention is given to the reproducibility crisis that scientific studies are still facing to date. In a recent study, not even half of all research antibodies mentioned in publications could be identified at all. This should spark more efforts in the search for practical solutions for the traceability of antibodies. For this purpose, we used 35 monoclonal antibodies against SARS-CoV-2 to demonstrate how sequence-independent antibody identification can be achieved by simple means applied to the protein. First, we examined the intact and light chain masses of the antibodies relative to the reference material NIST-mAb 8671. Already half of the antibodies could be identified based solely on these two parameters. In addition, we developed two complementary peptide mass fingerprinting methods with MALDI-TOF-MS that can be performed in 60 min and had a combined sequence coverage of over 80%. One method is based on the partial acidic hydrolysis of the protein by 5 mM of sulfuric acid at 99 degrees C. Furthermore, we established a fast way for a tryptic digest without an alkylation step. We were able to show that the distinction of clones is possible simply by a brief visual comparison of the mass spectra. In this work, two clones originating from the same immunization gave the same fingerprints. Later, a hybridoma sequencing confirmed the sequence identity of these sister clones. In order to automate the spectral comparison for larger libraries of antibodies, we developed the online software ABID 2.0. This open-source software determines the number of matching peptides in the fingerprint spectra. We propose that publications and other documents critically relying on monoclonal antibodies with unknown amino acid sequences should include at least one antibody fingerprint. By fingerprinting an antibody in question, its identity can be confirmed by comparison with a library spectrum at any time and context.
Im Vergleich zu anderen Proteinen ist die Identifizierung von Antikörpern anhand ihrer Sequenz zum Beispiel mittels "peptide mass fingerprinting" schwierig. Da die Sequenzinformation eines Antikörpers aufgrund der hypersomatischen Mutation während der Affinitätsreifung nicht im Genom eines Organismus gespeichert ist, kann die Aminosäuresequenz nicht auf einfachem Weg der DNA-Sequenzierung gewonnen werden. Das ist nur in seltenen Fällen möglich, wenn dem Endanwender der Zellklon der Antikörper-produzierenden Zelle zugänglich ist. Eine Sequenzierung auf Protein-Ebene ist sehr aufwändig und teuer und wird daher fast nie für die Charakterisierung von analytischen Antikörpern verwendet. Der Mangel an Validierung dieser analytischen Antikörper, die bei Experimenten verwendeten werden, löst aber eine Reihe Probleme aus, die die Wiederholbarkeit dieser Experimente schwierig und in einigen Fällen unmöglich macht. Das sorgt jährlich für verschwendete Forschungsgelder in Milliardenhöhe und hindert den wissenschaftlichen Fortschritt.
Ziel der vorliegenden Arbeit war die Entwicklung einer einfachen und schnellen Methode, die es trotzdem ermöglicht, die Identifikation von Antikörpern sicherzustellen. Dazu wurde eine Methode basierend auf dem "peptide mass fingerprinting" gewählt. Das Problem der unbekannten Aminosäuresequenz der Antikörper wurde gelöst, indem lediglich die Peptidmuster der entstehenden Fingerprint-Spektren zur Identifikation herangezogen wurden. MALDI wurde dabei als Ionisationsmethode für die Massenspektrometrie gewählt, da die resultierenden Spektren im Gegensatz zu ESI-MS einfach auszuwerten sind. Auch kann auf eine vorige Trennung der Peptide mittels LC verzichtet werden, was zusätzlich Analysenzeit spart. Für die Proteinspaltung wurde eine simple saure Hydrolyse mittels Ameisensäure gewählt. Im Vergleich zum herkömmlichen Trypsin-Verdau konnten auf zeitraubende Arbeitsschritte wie Denaturierung, Reduktion und Alkylierung der Antikörper verzichtet werden. Die Hydrolyse mittels Ameisensäure wurde bisher nur auf kleine und mittelgroße Proteine angewendet, sodass im ersten Teil dieser Arbeit mehrere Schritte optimiert wurden bevor zufriedenstellende Fingerprint-Spektren von Antikörpern erhalten wurden.
In dieser Arbeit wurden drei verschiedene Nanomaterialien auf ihre Bindungsfähigkeit zu Proteinen untersucht. Zu Beginn standen dabei die Herstellung stabiler Dispersionen der einzelnen Nanopartikel und die Stabilität der gebildeten Konjugate im Vordergrund. Der Nachweis einer erfolgreichen Konjugatbildung, sprich der Beschichtung von Nanopartikel mit Proteinen, wurde sowohl qualitativ mittels DLS-Messungen als auch über quantitative Protein-Bestimmungen erbracht. Für die Quantifizierung konnten verschiedene Methoden eingesetzt werden. Neben der klassischen Vorgehensweise, welche indirekt über die Quantifizierung von ungebundenem Protein im Überstand erfolgt, konnten ihm Rahmen dieser Arbeit verschiedene direkte Bestimmungsmethoden entwickelt werden. So wurden mittels kolorimetrischer Tests, wie dem BCA-Assay und dem Bradford-Assay, Nanodiamantdispersionen mit Hilfe einer Korrekturwellenlänge vermessen und quantifiziert. Ebenso zum Einsatz kam die Methode der Aminosäureanalytik, welche aufgrund ihrer guten Rückführbarkeit auf Aminosäurestandards Ergebnisse mit hoher Richtigkeit generieren kann und ebenso die Detektion kleiner Proteinmengen möglich macht.
Nach den erfolgten quantitativen Betrachtungen wurden die Protein-beschichteten Nanopartikel auf ihre Anwendbarkeit als Analoga von Virus-like Particles (VLP) bei einer Immunisierung zur Gewinnung von polyklonalen Antikörpern gegen humanes Ceruloplasmin in Kaninchen überprüft. Es konnte mittels ELISA gezeigt werden, dass die Konjugate erfolgreich für die Herstellung von Antikörpern eingesetzt werden können und im zeitlichen Verlauf einer Immunisierung eine Steigerung des Antikörper-Titers zu erreichen ist.
Vergleichende Darstellung SARS-CoV-2-spezifischer Nanobodys aus unterschiedlichen Wirtsorganismen
(2021)
Aufgrund der anhaltenden COVID-19-Pandemie werden neutralisierende Therapeutika benötigt. Eine Möglichkeit zur Behandlung stellt die Verwendung monoklonaler Anti-SARS-CoV-2-Immun-globuline dar. Ihre Produktion in Säugetierzellen ist jedoch schwer skalierbar, um den weltweiten Bedarf zu decken. VHH-Antikörper, auch Nanobodys genannt, bieten hierfür eine Alternative, da sie eine hohe Temperaturstabilität aufweisen und eine kostengünstige Produktion in prokaryotischen Wirtsorganismen ermöglichen.
Fast and accurate determination of the protein content of a sample is an important and non-trivial task of many biochemical, biomedical, food chemical, pharmaceutical, and environmental research activities. Different methods of total protein determination are used for a wide range of proteins with highly variable properties in complex matrices. These methods usually work reasonably well for proteins under controlled conditions, but the results for non-standard and complex samples are often questionable. Here, we compare new and well-established methods, including traditional amino acid analysis (AAA), aromatic amino acid analysis (AAAA) based on the amino acids phenylalanine and tyrosine, reversed-phase liquid chromatography of intact proteins with UV absorbance measurements at 220 and 280 nm (LC-220, LC-280), and colorimetric assays like Coomassie Blue G-250 dye-binding assay (Bradford) and bicinchoninic acid (BCA) assay. We investigated different samples, including proteins with challenging properties, chemical modifications, mixtures, and complex matrices like air particulate matter and pollen extracts. All methods yielded accurate and precise results for the protein and matrix used for calibration. AAA, AAAA with fluorescence detection, and the LC-220 method yielded robust results even under more challenging conditions (variable analytes and matrices). These methods turned out to be well-suited for reliable determination of the protein content in a wide range of samples, such as air particulate matter and pollen.